News Focus
News Focus
icon url

Carboat

11/26/16 6:04 AM

#279586 RE: biopharm #279583

CEO Steve King doing a great job on the science side

Huh? Bavi has failed every late stage trial. It is widely considered a huge error to have gone to PIII with Sunrise. That trial designed seemed flawed at best. The PII was totally botched. There have been 0 $$ deals. They are paying people to run trials for them at this point. If the science were great people would pay pphm. Pretty basic stuff.
icon url

TampaTradr

11/26/16 6:18 AM

#279587 RE: biopharm #279583

Everyone thought they were at the "buy low" stage years ago when it was trading over $2.

Don't hold your breath on it now.
icon url

CHEVYGUY

11/26/16 10:11 AM

#279590 RE: biopharm #279583

Has anyone heard of the 3rd reverse split?